See our recent news and announcements below. If you have any questions or for media inquiries, please contact email@example.com for assistance or see specified media contact details within each release.
Waltham, MA, August 31, 2020 – Pyramid Biosciences, Inc., a Boston-based biotechnology company developing new precision therapies focused on the modulation of cell surface receptors, today announced the close of $28 million USD in funding. The financing will accelerate the growth of Pyramid Biosciences’ programs focused on novel tropomyosin receptor kinase (TRK) modulators in oncology and dermatology disorders. [click to read more]